Seminars in Hematology
Volume 46, Issue 3 , Pages 269-276 , July 2009

Infections in Patients With Aplastic Anemia

  • Jessica M. Valdez

      Affiliations

    • Howard Hughes Medical Institute–National Institutes of Health Research Scholars Program, Bethesda, MD
    • Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD
    • ,
  • Phillip Scheinberg

      Affiliations

    • Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD
    • ,
  • Neal S. Young

      Affiliations

    • Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD
    • ,
  • Thomas J. Walsh

      Affiliations

    • Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD
    • Corresponding Author InformationAddress correspondence to Thomas J. Walsh, MD, Chief, Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, CRC 1-5750, 10 Center Dr, Bethesda, MD 20892

References 

  1. Young NS, Scheinberg P, Calado RT. Aplastic anemia. Curr Opin Hematol. 2008;15:162–168
  2. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108:2509–2519
  3. Weinberger M, Elattar I, Marshall D, Steinberg SM, Redner RL, Young NS, et al. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore). 1992;71:24–43
  4. Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Leaverton PE, Shapiro S, et al. The epidemiology of aplastic anemia in Thailand. Blood. 2006;107:1299–1307
  5. Hamerschlak N, Maluf E, Pasquini R, Eluf-Neto J, Moreira FR, Cavalcanti AB, et al. Incidence of aplastic anemia and agranulocytosis in Latin America—the LATIN study. Sao Paulo Med J. 2005;123:101–104
  6. Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 1995;85:3058–3065
  7. Young NS, Kaufman DW. The epidemiology of acquired aplastic anemia. Haematologica. 2008;93:489–492
  8. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine (The German Aplastic Anemia Study Group). N Engl J Med. 1991;324:1297–1304
  9. Frickhofen N, Rosenfeld SJ. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine. Semin Hematol. 2000;37:56–68
  10. Scheinberg P, Nunez O, Wu C, Young NS. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. Br J Haematol. 2006;133:606–611
  11. Tisdale JF, Dunn DE, Geller N, Plante M, Nunez O, Dunbar CE, et al. High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet. 2000;356:1554–1559
  12. Young NS. Acquired aplastic anemia. Ann Intern Med. 2002;136:534–546
  13. Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis. 1999;1:247–261
  14. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–360
  15. Trigg ME, Menezes AH, Giller R, Lanza L, Smith RJ, Sato Y, et al. Combined anti-fungal therapy and surgical resection as treatment of disseminated aspergillosis of the lung and brain following BMT. Bone Marrow Transplant. 1993;11:493–496
  16. Andriole VT. Infections with Aspergillus species. Clin Infect Dis. 1993;17(Suppl 2):S481–S486
  17. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA, et al. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med. 1984;100:345–351
  18. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–653
  19. Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn RM, Walsh TJ. Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis. 2005;191:1180–1187
  20. Parfrey NA. Improved diagnosis and prognosis of mucormycosis (A clinicopathologic study of 33 cases). Medicine (Baltimore). 1986;65:113–123
  21. Van Steenweghen S, Maertens J, Boogaerts M, Deneffe G, Verbeken E, Nackaerts K, et al. Mucormycosis, a threatening opportunistic mycotic infection. Acta Clin Belg. 1999;54:99–102
  22. Palmer LB, Greenberg HE, Schiff MJ. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax. 1991;46:15–20
  23. Roilides E, Walsh T. Recombinant cytokines in augmentation and immunomodulation of host defenses against Candida spp. Med Mycol. 2004;42:1–13
  24. Bendel WL, Race GJ. Acute disseminated candidiasis in aplastic anemia (Potentiation by antibiotics and steroids). Arch Intern Med. 1961;108:916–924
  25. Segal BH, Walsh TJ, Liu JM, Wilson JD, Kwon-Chung KJ. Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia. J Clin Microbiol. 1998;36:1772–1776
  26. el-Ani AS. Disseminated infection caused by Fusarium solani in a patient with aplastic anemia. N Y State J Med. 1990;90:609–610
  27. Girmenia C, Iori AP, Boecklin F, Torosantucci A, Chiani P, De Fabritiis P, et al. Fusarium infections in patients with severe aplastic anemia: review and implications for management. Haematologica. 1999;84:114–118
  28. Nucci M, Pulcheri W, Spector N, Maiolino A, Caiuby MJ, Maceira J, et al. Cutaneous involvement of systemic fungal infections in neutropenic patients. Haematologica. 1992;77:522–523
  29. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect. 1994;28(Suppl 1):7–15
  30. Spielberger RT, Falleroni MJ, Coene AJ, Larson RA. Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient. Clin Infect Dis. 1993;16:528–530
  31. Erer B, Galimberti M, Lucarelli G, Giardini C, Polchi P, Baronciani D, et al. Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts. Bone Marrow Transplant. 2000;25:745–749
  32. Walsh TJ, Lee JW, Melcher GP, Navarro E, Bacher J, Callender D, et al. Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J Infect Dis. 1992;166:121–133
  33. Munoz FM, Demmler GJ, Travis WR, Ogden AK, Rossmann SN, Rinaldi MG, et al. Trichoderma longibrachiatum infection in a pediatric patient with aplastic anemia. J Clin Microbiol. 1997;35:499–503
  34. Wood GM, McCormack JG, Muir DB, Ellis DH, Ridley MF, Pritchard R, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis. 1992;14:1027–1033
  35. Wang SC, Hsueh PR, Liaw SJ, Chang LY, Lu CY, Jou ST, et al. Fatal fungemia due to Phaeoacremonium inflatipes in a child with severe aplastic anemia. Clin Infect Dis. 2005;40:1067–1068
  36. Aquino VM, Norvell JM, Krisher K, Mustafa MM. Fatal disseminated infection due to Exserohilum rostratum in a patient with aplastic anemia: case report and review. Clin Infect Dis. 1995;20:176–178
  37. Torres HA, Bodey GP, Rolston KV, Kantarjian HM, Raad II, Kontoyiannis DP. Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer. 2003;98:86–93
  38. Keidan AJ, Tsatalas C, Cohen J, Cousins S, Gordon-Smith EC. Infective complications of aplastic anaemia. Br J Haematol. 1986;63:503–508
  39. Doney KC, Weiden PL, Buckner CD, Storb R, Thomas ED. Treatment of severe aplastic anemia using antithymocyte globulin with or without an infusion of HLA haploidentical marrow. Exp Hematol. 1981;9:829–834
  40. Rolston KV. Expanding the options for risk-based therapy in febrile neutropenia. Diagn Microbiol Infect Dis. 1998;31:411–416
  41. Dearden C, Foukaneli T, Lee P, Gordon-Smith EC, Marsh JC. The incidence and significance of fevers during treatment with antithymocyte globulin for aplastic anaemia. Br J Haematol. 1998;103:846–848
  42. Andreoli-Pinto TJ, Graziano KU. Important aspects of the colonization of central venous catheter. Boll Chim Farm. 1999;138:19–23
  43. Wolf HH, Leithauser M, Maschmeyer G, Salwender H, Klein U, Chaberny I, et al. Central venous catheter-related infections in hematology and oncology: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2008;87:863–876
  44. Strauss R, Mueller A, Wehler M, Neureiter D, Fischer E, Gramatzki M, et al. Pseudomembranous tracheobronchitis due to Bacillus cereus. Clin Infect Dis. 2001;33:E39–E41
  45. Ueda K, Konishi M, Maeda K, Hamada K, Sakamoto M, Yoshimoto E, et al. [Bacillus cereus septicemia in a patient with severe aplastic anemia]. Kansenshogaku Zasshi. 1998;72:1325–1329
  46. Henrickson KJ, Shenep JL, Flynn PM, Pui CH. Primary cutaneous bacillus cereus infection in neutropenic children. Lancet. 1989;1:601–603
  47. Drobniewski FA. Bacillus cereus and related species. Clin Microbiol Rev. 1993;6:324–338
  48. Chuansumrit A, Hathirat P, Isarangkura P. Acquired aplastic anemia in children: a review of 100 patients. Southeast Asian J Trop Med Public Health. 1990;21:313–320
  49. Tamaskar I, Segota E, Kalaycio M, Maciejewski J. The clinical picture (A woman with aplastic anemia and a rash). Cleve Clin J Med. 2006;73:1088–1090
  50. Sirinavin S, Likitnukul S, Lolekha S. Aeromonas septicemia in infants and children. Pediatr Infect Dis. 1984;3:122–125
  51. Al-Anazi KA, Al-Jasser AM, Al-Zahrani HA, Chaudhri N, Al-Mohareb FI. Klebsiella oxytoca bacteremia causing septic shock in recipients of hematopoietic stem cell transplant: two case reports. Cases J. 2008;1:160
  52. Lasala PR, Smith MB, McGinnis MR, Sackey K, Patel JA, Qiu S, et al. Invasive Exserohilum sinusitis in a patient with aplastic anemia. Pediatr Infect Dis J. 2005;24:939–941
  53. Fox BC, Ross DD, Huang AB, Gabrielson EW, Furth PA. Mycobacterial disease associated with aplastic anaemia. J Infect. 1989;19:157–165
  54. Chen RL, Lin KH, Chen BW, Su S, Lin DT, Chuu WM, et al. Long-term observation of pediatric aplastic anemia. J Formos Med Assoc. 1992;91:390–395
  55. Allard S, O'Driscoll J, Laurie A. Salmonella osteomyelitis in aplastic anaemia after antilymphocytic globulin and steroid treatment. J Clin Pathol. 1992;45:174–175
  56. Walsh Thomas J, Hamilton Stanley R. Bacterial esophagitis in immunocompromised patients. MNJB, MD; MD. Arch Intern Med. 1985;46:1345–1348
  57. Sears CL. A dynamic partnership: celebrating our gut flora. Anaerobe. 2005;11:247–251
  58. Beaugerie L, Petit JC. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol. 2004;18:337–352
  59. Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis. 2000;31:705–711
  60. Fergie JE, Patrick CC, Lott L. Pseudomonas aeruginosa cellulitis and ecthyma gangrenosum in immunocompromised children. Pediatr Infect Dis J. 1991;10:496–500
  61. Kato N, Morioka T. Purpura fulminans secondary to Xanthomonas maltophilia sepsis in an adult with aplastic anemia. J Dermatol. 1991;18:225–229
  62. Chun WH, Kim YK, Kim LS, Ko YW, Bang D. Ecthyma gangrenosum associated with aplastic anemia. J Korean Med Sci. 1996;11:64–67
  63. Tsuzuki M, Ino T, Maruyama F, Okamoto M, Ezaki K, Hirano M, et al. Vibrio vulnificus septicemia in a patient with severe aplastic anemia. Int J Hematol. 1998;67:175–178
  64. Van Eldere J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother. 2003;51:347–352
  65. Bodey GP, Bolivar R, Fainstein V, Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis. 1983;5:279–313
  66. Scheinberg P, Fischer SH, Li L, Nunez O, Wu CO, Sloand EM, et al. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood. 2007;109:3219–3224
  67. Muennig P, Pallin D, Challah C, Khan K. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States. Epidemiol Infect. 2004;132:1055–1063
  68. Muennig P, Pallin D, Sell RL, Chan MS. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. N Engl J Med. 1999;340:773–779
  69. Osterwalder B, Gratwohl A, Nissen C, Hasse J, Gradel E, Dalquen P, et al. [Invasive pulmonary aspergillosis—a diagnostic and therapeutic problem in patients with severe aplastic anemia]. Schweiz Med Wochenschr. 1985;115:378–380

PII: S0037-1963(09)00063-8

doi: 10.1053/j.seminhematol.2009.03.008

Seminars in Hematology
Volume 46, Issue 3 , Pages 269-276 , July 2009

Article Tools